pfizer - Search News

Pfizer names former FDA director

Pfizer names former FDA director as chief medical officer

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory and drug safety operations.

STAT · 11h

Patrizia Cavazzoni, former head of FDA’s drug center, joins Pfizer as chief medical officer

Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.

FierceBiotech · 13h

Ex-CDER chief Patrizia Cavazzoni becomes Pfizer’s chief medical officer

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., is returning to her previous employer: Big Pharma Pfizer. | After leaving the FDA,

Pfizer, ADCs and Summit

FierceBiotech · 15h

Pfizer to test Summit's white-hot bispecific with ADCs

Pfizer has teamed up with Summit Therapeutics to assess whether one of the industry’s hottest cancer candidates works well with its antibody-drug conjugates (ADCs). Miami-based Summit holds the rights to the PD-1xVEGF bispecific ivonescimab in territories including the U.

GlobalData on MSN · 10h

Pfizer sets sights on Summit’s bispecific in combo with its ADCs

Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summit’s ivonescimab in combination with several of its ADCs.

Seeking Alpha · 13h

Pfizer: What The Summit Therapeutics Deal Brings

Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why PFE stock is a Buy.

STAT10h

Pfizer CEO Albert Bourla inflicts injury on his company — and all of pharma

The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

13h

Pfizer shelves Beqvez, a Spark Therapeutics developed product

Here's why a gene therapy product originally developed at CHOP spinout Spark Therapeutics was shelved by Pfizer.

Zacks.com on MSN14h

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

3don MSN

Trump Introducing Pfizer CEO Sparks Loud Booing Inside White House

A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...

Pfizer stops commercialization of hemophilia gene therapy Beqvez

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

13h

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, ...

Hosted on MSN13h

Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan Pharmaceuticals

The shares of Pfizer zoomed 8.6% to a high of Rs 4,448.35 on the BSE today after the company on Friday announced that it ...

18h

Driving Patient-Centric Innovation in Life Sciences Using Generative AI with Pfizer

Supporting Rapid Innovation through the PACT Initiative. Pfizer has focused on scientific innovation as a core value since it ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Pfizer names former FDA director

Pfizer, ADCs and Summit

Related topics